Hematopoietic stem cells (HSCs) are responsible for the generation of blood and immune cells throughout life.
. Proteomics of mouse hematopoiesis workflow. A. The hematopoietic tree. Hematopoietic stem cells (HSCs) giv multipotent progenitors (MPPs). Fate commitment arises in the oligopotent progenitor (OPP) compa megakaryocyte/erythrocyte progenitors (MEPs), common myeloid progenitors (CMPs), common lymphoid progenitors (CL granulocyte/macrophage progenitors (GMPs). B. Proteomic sample preparation workflow: a. bone marrow cells are isolate single cell suspension generated b. cells are stained with a panel of antibodies c. cells are sorted by FACS. d. cells are ly protein amounts normalized e. lysate is digested and desalted f. peptides are subjected to mass spectrometry analysis g. raw processed and analyzed to generate datasets.
Introduction
Hematopoietic stem cells (HSCs) allow for persistent renewal of blood and immune cells throughout a li They have the ability to not only self-renew but also differentiate into effector cells in response to physio demands such as infection or bleeding ( Figure 1A ) (Seita and Weissman, 2010) . Due to their unique capa and therapeutic promise in regenerative medicine, organ transplantation and hematological malignanc pre-malignancies, the biology behind HSCs and their progeny has been of extreme interest to the scienti medical communities since Till and McCulloch's first indication of their existence in 1961-68 (Weissm Shizuru, 2008) . It has since been demonstrated that HSCs can give rise to non-committed mult progenitor cells (MPPs) that move through differentiation, eventually committing to a more-defined cell the oligopotent progenitor (OPP) compartment ( Figure 1A ) (Akashi et al., 2000; Kondo et al., 1997) . Th compartment consists of fate-restricted cell types: the common myeloid progenitor (CMP), the granu ive rise to partment: CLPs) and lated and a lysed and raw data is The OPP nulocyte-macrophage progenitor (GMP), the megakaryocyte-erythroid progenitor (MEP) and the common lymphoid progenitor (CLP) ( Figure 1A) . Importantly, mouse and human hematopoietic cell surfaces are dramatically reengineered during differentiation. Over the past 30 years, surface proteins have been identified and differential expression phenotypically characterized, allowing for purification of phenotypically-distinct cell populations through single-cell sorting in conjunction with a panel of fluorescent antibodies (Ema et al., 2006; Kiel et al., 2005; Majeti et al., 2007; Miller and Eaves, 1997; Morrison and Weissman, 1994; Spangrude et al., 1988) .
Blood malignancies and cytopenias can be successfully treated with purified HSC transplants and are also used during organ transplantation to promote engraftment and tolerance (Gandy et al., 1999; Shizuru et al., 1996; Uchida et al., 1998) . Transplanted purified HSCs can completely reconstitute blood lineages in conditioned mice without causing graft vs. host disease in an allogeneic setting. Harsh conditioning regimens have previously been required prior to allogeneic transplant. However, we and others have reported the use of an antibody depletion cocktail which can be used in lieu of traditional chemotherapy and irradiation strategies, increasing the potential application of hematopoietic cell transplantations well beyond otherwise-fatal malignancies (Chhabra et al., 2016; Czechowicz et al., 2007; George et al., 2019) . These transformative developments further emphasize our need to completely understand HSC maintenance and fate determination and how hematopoiesis is altered during disease and aging.
The dynamics of HSC biology have revealed unique behaviors employed by these cells to maintain stem-like properties. During aging, HSC populations become less self-renewing and exhibit a myeloid-biased fate, prompting expansion of the HSC pool and an increase in CMP production (Beerman et al., 2010; Muller-Sieburg et al., 2004; Pang et al., 2011) . Aged HSCs can give rise to imbalanced output and misregulated progenitor cells, resulting in the presentation of cytopenias before onset of a treatable disease (Jaiswal et al., 2014) . Clonal hematopoiesis of indeterminate potential (CHIP) is associated with blood cancers, atherosclerosis and premature death (Jaiswal et al., 2014; . In pre-malignancies, diseased HSCs outcompete healthy HSCs for their coveted bone marrow niche and thus become the primary drivers of blood formation Jan et al., 2012; Pang et al., 2013) . Investigation into the mechanisms behind such biological phenomena can provide insight into genes and proteins critical for HSC fate and function.
Given the historical challenge of collecting enough of these cells for experimental studies, much of what is known about HSCs and their progeny has been discovered through DNA microarray, bulk and single-cell RNAsequencing and ATAC-sequencing experiments. Functional transplant studies and/or phenotypic genetic knockout mouse models have been the cornerstones of our understanding for how HSCs maintain stemness and determine their fate (Lu et al., 2011) . While there is currently an abundance of genomic and transcriptomic sequencing available, very little proteomic or metabolomic investigation has been conducted (Buenrostro et al., 2018; Cabezas-Wallscheid et al., 2014; Galeev et al., 2016; Seita et al., 2012) . Recent publications suggest that the hematopoietic hierarchy is more nuanced and less single-path driven than originally thought (Rodriguez-Fraticelli et al., 2018; Sanjuan-Pla et al., 2013; Yamamoto et al., 2018a; 2018b) . These discoveries emphasize that there is still much to be uncovered in our understanding of HSC and progenitor biology.
Large scale mRNA and genomic sequencing studies provide insight into the consequences of perturbations in gene expression during differentiation, development, disease and aging, but we still lack a complete understanding of how genes drive function through protein expression. It has been well documented that mRNA abundance and protein expression are not well correlated (Gygi et al., 1999; Koussounadis et al., 2015; Liu et al., 2016) . Additionally protein translation studies in HSCs suggest multiple modes in the regulation of protein expression, and therefore determining mRNA levels of proteins of interest is insufficient for a complete understanding of the hematopoietic protein profile in stem and progenitor compartments .
There are many lines of evidence that suggest HSCs exhibit minimal regulation at the genomic and transcript level. Previous reports have demonstrated that protein synthesis is tightly regulated in the HSC compartment compared to downstream progenitors and altering this rate of translation impairs HSC function . Rates of protein synthesis are significantly lower in HSCs compared to downstream progenitors and, importantly, these discrepancies cannot be entirely explained by differences in ribosomal RNA and total cellular RNA content (Buszczak et al., 2014; Signer et al., 2014) . It has also been demonstrated that HSCs present more open chromatin compared to that of progenitors (Miyamoto et al., 2002; Yu et al., 2016) . In single cell ATACseq data, chromatin accessibility landscapes were determined to be highly variable in early-stage hematopoietic cells, suggesting reduced regulation at the chromatin level and increased message diversity (Buenrostro et al., 2018) . These data further support a hypothesis whereby protein translation is the vital regulatory step in HSC fate determination, and a complete understanding of the suite of proteins expressed by each cell type during hematopoiesis can provide further insight into the biological mechanisms at play.
Previously, Trumpp and co-workers reported comparative proteomic data between HSCs and early MPP1 progenitors (Lin -, Sca1 + , cKIT + , CD34 + , CD48 -, CD150 + ), which provides insight exclusively into proteins critical to the earliest stage in hematopoiesis (Cabezas-Wallscheid et al., 2014) . Palii et. al. have utilized targeted mass cytometry to characterize expression of specific transcription factors critical to human erythropoiesis (Palii et al., 2019) . Proteomics of mixed populations of mouse HSC stem and progenitor cells (Lin -, Sca1 + , cKIT + ) in fetal and adult has been reported by Hansson and co-workers, but the imbalance in proteomic contribution between HSCs and progenitors in the multipotent and oligopotent compartments does not allow for further insight into the fate and function of each specific cell type (Jassinskaja et al., 2017) .
Currently, we lack an understanding of protein expression across early hematopoiesis, including HSCs, MPPs (MPPa, b and c) and OPPs (CMP, GMP, MEP, CLP). This knowledge gap hampers our ability to determine key players in biochemical processes critical to hematopoiesis, to identify cell-specific surface proteins for improved purification strategies and to discover novel therapeutic protein targets.
HSCs are very rare and often difficult to purify, presenting a formidable challenge for traditional biochemical methods of investigation. Approximately 0.01-0.001% of mononuclear cells in the bone marrow of adult humans and mice are HSCs, and therefore experiments requiring large amounts of highly-pure starting material, such as cell lysate, have not been technically achievable (Mayle et al., 2013) . Recently the Mann laboratory reported the use of mass spectrometry instrumentation capable of increased sensitivity and improved proteomic coverage with very low amounts of protein (Meier et al., 2018) . This technology allows for unprecedented coverage from samples under 200 ng, dramatically improving the feasibility of performing large-scale proteomics studies on rare cell types.
With this technology available to us and our awareness of the incomplete profiling of the hematopoietic proteome, we sought to complement and elaborate upon these data with a comprehensive unbiased proteomics database characterizing protein expression throughout the mouse adult hematopoietic hierarchy from HSCs through the multipotent and oligopotent progenitor compartments as well in aged HSCs and MPPs. The database has been validated through FACS and fluorescence microscopy experiments for proteins of interest. In comparing our proteomics database with bulk mRNA sequencing from HSCs, MPPas, MPPbs and MPPcs we identified a unique relationship between transcription and translation exclusive to the HSC compartment.
Finally, these protein expression data are now integrated into a resource that allows for researchers to understand not only how mRNA levels change for genes of interest but also how protein expression is altered during adult and aged hematopoiesis.
Results

Optimization of sample preparation for low numbers of rare cells
Critical to our ability to deeply characterize protein expression was the development of a method by which to efficiently purify and process samples for mass spectrometry analysis from under 100,000 cells. To this end, we created a workflow whereby cells were purified by FACS using three sorting panels allowing for the isolation of 8 cells types: HSC (Lin -, cKIT + , Sca1 + , CD34 -, CD150 + , Flt3 -), MPPa (Lin -, cKIT + , Sca1 + , CD34 + , CD150 + , Flt3 -), MPPb (Lin -, cKIT + , Sca1 + , CD34 + , CD150 -, Flt3 -), MPPc (Lin -, cKIT + , Sca1 + , CD34 + , CD150 -, Flt3 + ), CLP (Lin -, CD34 med/hi , Flt3 + , IL7Rα + , cKIT lo , Sca1 lo ), CMP (Lin -, cKIT + , Sca1 lo/-, CD34 med/hi , CD16/32 -/lo ), MEP (Lin -, cKIT + , Sca1 lo/-, CD34 -, CD16/32 -/lo , CD150 + ) and GMP (Lin -, cKIT + , Sca1 lo/-, CD34 hi , CD16/32 hi ) ( Figure 1 and Supplemental Figures 1A, 1B and 1C ). Cells were purity sorted into FACS buffer (2% fetal bovine serum in PBS) and washed twice with PBS to remove any remaining serum prior to storage. Samples for mass spectrometry analysis were prepared with a minimum of 50,000 cells ( Figure 1B) . A commerciallyavailable mass spectrometry sample preparation kit was utilized to ensure minimal sample loss and reproducibility and proved critical to our efforts ( Figure 1B A database of proteins expressed by rare cell types
In order to generate a repository of proteins expressed by HSCs and their progenitors that are detectable by mass spectrometry, we divided each protein intensity by the total protein intensity per technical replicate and multiplied by 1 million for ease of analysis (Table 1 ). An average was taken within each cell type for global analyses (Table 2 ). Across all cell types we detected a total of 7917 genes encoding proteins expressed and detectable in HSCs and their progenitors (Tables 1 and 2 ). The adult HSC compartment had the least protein diversity, with 4030 proteins detected ( Figure 2A ). We observed a general trend in increased protein diversity during the differentiation process, with MPPs and OPPs expressing larger numbers of distinct proteins compared to HSCs (Figure 2A ).
This result differs from previous reports where HSCs have been demonstrated to present increased mRNA diversity in the stem cell compartment compared to their progeny (Ramos et al., 2006) .
Characterization of protein expression in HSCs and their progenitors
With our database generated, we next validated detection of known markers of stem and progenitor cells, including cKIT and CD150/Slamf1 (Figures 2B and 2C ). As expected, cKIT was detected across all cell types with expression high in HSCs, MPPs and lower in CLPs and GMPs. CD150/Slamf1 expression was exclusive to HSC and MPPa compartments, an attestation to the purity of these sorted samples. The cell-cycle associated protein ki67 was lowly detected in the HSC compartment with a steady increase in expression in the MPP compartment and highest in the OPPs (Supplemental Figure 1D ). Principal component analysis (PCA) revealed exquisite distribution of adult hematopoietic stem and progenitor cells during differentiation ( Figure 2D , Table   4 ). Excitingly, each component revealed unique attributes driving differentiation: component 1 isolates HSCs from all other cell types, whereas component 2 separates stem and multipotent progenitors from the morecommitted oligopotent progenitor compartment ( Figure 2E and Table 4 ).
Validation of differential expression of proteins of interest
To validate additional targets using non-mass spectrometry techniques, we performed FACS analysis and fluorescence microscopy. The endothelial surface adhesion molecule (ESAM) has previously been shown to be highly expressed by HSCs (Ishibashi et al., 2016; Ooi et al., 2009; Yokota et al., 2009) proteomic expression data further support a glycolytic advantage in the HSC compartment (Ito and Suda, 2014) .
Takubo et al. have also reported that PDK2-and PDK4-mediated regulation of anaerobic glycolysis in longterm HSCs modulates stemness and arrests cell cycle (Takubo et al., 2013) . While we identify PDK2 and PDK3 in our datasets, we did not observe increased expression of these proteins, as detectable by mass spectrometry (Tables 1 and 2) . This discrepancy may be due to several explanations, including low rates of detection and differences in selection markers used for each cell type. Nevertheless, differential expression of glycolytic enzymes between HSCs and progenitors remains consistent throughout all reports.
We also compared our HSC (Lin -, cKIT + , Sca1 + , CD34 -, CD150 + , Flt3 -) and MPPa (Lin -, cKIT + , Sca1 + , CD34 + , CD150 + , Flt3 -), data to that of Trumpp and co-workers' comparative proteomics data between HSC (Lin -, Sca1 + , cKIT + , CD34 -, Flt3 -, CD48 -, CD150 + ) and MPP1 (Lin -, Sca1 + , cKIT + , CD34 + , Flt3 -, CD48 -, CD150 + ) cell types ( Figure   4B ).
Identification of further potential proteins of study
Over 40% of proteins were detected across all cell types ( Figure 4A ). With deep proteome coverage and analysis of progenitor populations, we were also able to identify proteins uniquely absent or uniquely detected in a single cell type ( Figure 4A and Table 3 ). To validate that differential expression profiles were not predominantly due to global differences in protein detection across cell types, we looked at expression of the Figure 4B ). Importantly, protein expression was consistent across all cell types characterized. In investigating uniquely expressed proteins, particularly the 340 proteins exclusively expressed in the GMP compartment, we identified GMP-specific proteins including CCAAT-enhancer-binding protein ε (Cebpe), Adhesion G Protein-Coupled Receptor G3 (Adgrg3) and Membrane-spanning 4-domains, subfamily A, member 3 (Ms4a3), all of which have previously been reported to be associated with macrophage and granulocyte-specific lineage commitment (Tables 1-3) (Goardon et al., 2011; Hsiao et al., 2018; Ishibashi et al., 2018; Nakajima et al., 2006) . In the HSC compartment, Igf2bp2 was detected as a uniquely expressed protein, as has previously been identified as differentially expressed by HSCs compared to MPP1s and MPPas (Supplemental Figure 4A) (Cabezas-Wallscheid et al., 2014) . We also identified 619 proteins that were detected in all other cell types besides HSCs ( Figure 4A ). Anamorsin (Cpin1), a protein encoded by the gene Ciapin1, and the transcription factor Activity-dependent neuroprotector homeobox (Adnp) were identified throughout MPP and OPP compartments but notably absent in HSCs ( Figure 4C ). Cpin1 is a protective anti-apoptotic protein that is required for maturation of erythroid cells but has been shown to not affect the number of stem and early progenitors cells (Shibayama et al., 2004) . Adnp is a transcriptional regulator implicated in neural development that also affects erythropoiesis (Dresner et al., 2012; Mandel et al., 2007) .
Characterization of protein expression in Aged HSCs and MPPs
Blood formation during aging is marked by a myeloid bias and higher frequency but lower engraftment per HSC transplanted as described previously (Jaiswal et al., 2014; Morrison et al., 1996; Pang et al., 2011) .
However, to the best of our knowledge, no mass spectrometry-based proteomics experiments have characterized protein expression changes in the HSC compartment during aging. Using our sort schemes and sample preparation methods, we purified and processed HSCs and MPPs from mice no less than 24 months of age ( Figures 1 and Supplemental Figures 1A, 1B and 1C ). Data analysis revealed expression of 5434 proteins in Aged HSCs ( Figure 5A, and Tables 1 and 2) . PCA analysis demonstrated the high similarity between adult and aged HSCs as compared to progenitor cells but also important differences across both component 1, where aged HSCs lose the distinctness of adult HSCs, and component 2, where aged HSCs seem to occupy a unique protein signature in comparison to both adult stem and progenitor compartments ( Figure 5B and Table 6 ). As expected, cKIT was consistently detected in all 4 cell types while CD150/Slamf1 was found in HSCs and MPPas exclusively ( Figure 4C ). Earlier FACS separation of CD150 hi and CD150 lo HSCs revealed CD150 hi HSCs are myeloid biased, and this sub-population increases most-dramatically in aged mice (Beerman et al., 2010) . Our proteomics data revealed similar variations in CD150 expression levels, with the range lowest in adult HSCs.
Additionally, cKIT expression was much higher in the aged cells compared to their adult counterparts, which has also been observed by others (Beerman et al., 2010; Mann et al., 2018) . Finally, Ki67 expression was still lower in the aged HSC compartment compared to that of adult and aged downstream progenitors (Supplemental Figure 5A ).
Given the abundance of functional studies that have been conducted to identify genes implicated in HSC fate determination and stemness, we were interested to compare our findings of differentially expressed proteins during adult vs. aged hematopoiesis with previous reports. von-Willebrand Factor (vWF) expression is associated with myeloid and platelet biases during hematopoiesis, and we also detected increased expression of vWF in aged HSCs and MPPas ( Figure 5D ) (Grover et al., 2016; Mann et al., 2018; Pinho et al., 2018; Sanjuan-Pla et al., 2013) . Integrin surface proteins are critical in mediating a pro-inflammatory response that can elicit bias in HSC fate determination, and such proteins are also well documented to exhibit increased expression during aging in addition to inflammatory events (Gekas and Graf, 2013; Haas et al., 2015; Mann et al., 2018; Pang et al., 2011) . We detected ITGA2b (CD41) expression in aged HSCs, which has been demonstrated to induce a myeloid bias, but, similar to Mann et. al., we did not see a significant difference between aged and adult (Tables 1 and 2) (Gekas and Graf, 2013; Mann et al., 2018) . However, expression of the complementary signaling molecule ITGB3 (CD61) increased significantly in the aged compartments of HSCs, MPPas and MPPbs, as described previously by Regev, Baltimore and co-workers (Supplemental Figure 5B ) . Finally, we investigated how protein expression of Cpin1 and Adnp changes during aging and determined that expression of both proteins is rescued in the aged HSC compartment (Supplemental Figure 5C ).
mRNA abundance comparison
Globally, mRNA expression and protein abundance are not well correlated across yeast and higher eukaryotes (Liu et al., 2016) . We were interested to determine if there were changes in the relationship between mRNA and protein during hematopoiesis, both broadly across the proteome as well as for specific proteins of interest. Bulk mRNA sequencing was conducted from adult mouse HSCs, MPPas, MPPbs and MPPcs as described previously (Table 7 ) (Moraga et al., 2015) . Spearman correlation coefficients (ρ) were calculated to determine the degree of monotonic relationship between mRNA and protein for HSCs, MPPas, MPPbs and MPPcs ( Figure 6A ). Correlation was lowest for the HSC compartment, which supports data generated by Signer, Morrison and co-workers suggesting that protein translation is uniquely regulated in the HSC compartment at least in part through a mechanism other than altered gene transcription . We 
Discussion
This resource provides unprecedented coverage of protein expression for adult and aged hematopoietic stem cells and their progenitors.
We validated the quality of our data via multiple methods. Our data are consistent with the expression of Put simply, some RNAs may not be translated, and their presence could reflect the opening of their chr rather than the need for these proteins to be translated within the HSC compartment. Our PCA also supp idea that HSCs exhibit minimal regulation at the genomic and transcript level. The bottom 250 p contributing to component 1 of the adult PCA, that is proteins less expressed in HSCs compared to all ot types, enriched for proteins involved in "chromatin silencing", "histone modification", and "
processing". Taken together with previous literature reports on protein translation and chromatin structur HSC compartment, these data suggest a new hypothesis in the regulation of stem maintenance an homeostasis (Figure 7) . RNA levels (mRNA and ribosomal) are comparable in HSCs compared to pro cells, and it has been reported that HSCs have more open chromatin than MPPs, suggesting an in plasticity in gene transcription (Buenrostro et al., 2018) . Conversely, protein translation is markedly r and highly sensitive to perturbations in the HSC compartment, and we now report a lower correlation b mRNA and protein . We therefore propose that perhaps primary regulatory mechan stemness shift downstream of gene transcription towards protein translation specifically in the compartment (Figure 7 ). ion of the HSC compartment based on the different stages of cell cycle. This can be important for our analysis of protein expression changes throughout early hematopoiesis, as HSCs are more quiescent than downstream progenitors, which can contribute to differential expression of proteins as a consequence of cell cycle. However, Signer,
Morrison and co-workers have reported that differences in the rates of protein translation between HSCs and MPPs cannot be entirely explained by cell-cycle. Our data reveal global differential regulation in protein expression, some of which will be cell cycle-dependent as well as -independent . Given the dearth of proteomic information currently available for these rare cells, this resource reveals previouslyuncharacterized suites of proteins detectable in adult and aged hematopoietic stem cell and progenitors. The nature of these expansive data allows not only for the identification of novel surface markers of each cell type but also provides an understanding of intracellular regulatory proteins of gene transcription, protein translation and metabolism that contribute to stem-and progenitor-cell survival, fate commitment and function.
